We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Bloodless Surgery Techniques for Tumor Removal

By HospiMedica staff writers
Posted on 28 May 2001
New techniques offer a way to surgically remove an aggressive pancreatic tumor without any transfusions during the operation or at any time afterward. More...
The techniques were developed at the New Jersey Institute for the Advancement of Bloodless Medicine & Surgery at Englewood Hospital and Medical Center (Englewood, USA) by Dr. Herbert Dardik, acting chief of the department of surgery.

The tumor patient refused to have a blood transfusion due to religious beliefs and had been turned away by several other hospitals because of this need and the potential for heavy blood loss. Since the tumor had grown beyond the pancreas into the adjacent vein, Dr. Dardik decided to remove the vein with the tumor as part of a radical Whipple procedure. Once the diseased vessel was removed, a Teflon graft was sewn in place to connect the intestinal blood circuit to the liver circuit.

In order to ensure continued flow of blood during the procedure and to prevent or minimize intestinal congestion, a temporary shunt consisting of a sterile segment of polyvinyl tubing was placed between the two veins that would be connected. This shunt was removed just before the last sutures were in place and blood flow was re-established. The focus of this technique is to prevent blood congestion in the intestines and deficient flow of blood to the liver. The use of a temporary shunt appears to eliminate these problems and supports surgeons in their efforts to perform radical venous resections and reconstructions with increasing simplicity, says Dr. Dardik.

In preparation for the operation, to address the possibility of potential blood loss, the patient was given erythropoietin for a period of several weeks prior to the operation. The operation was then performed using the technique of acute normovolemic hemodilution (ANH) in combination with a cell-saving device. In accordance with transfusion-free techniques, some blood was removed from the patient just before surgery. The blood was retained within a closed system and about 15% of red blood cells were reinfused.





Related Links:
Englewood Hospital

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.